1. Home
  2. ALTO vs AKBA Comparison

ALTO vs AKBA Comparison

Compare ALTO & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alto Ingredients Inc.

ALTO

Alto Ingredients Inc.

N/A

Current Price

$3.73

Market Cap

282.7M

Sector

Industrials

ML Signal

N/A

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

N/A

Current Price

$0.39

Market Cap

248.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ALTO
AKBA
Founded
2003
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
282.7M
248.3M
IPO Year
2005
2014

Fundamental Metrics

Financial Performance
Metric
ALTO
AKBA
Price
$3.73
$0.39
Analyst Decision
Strong Buy
Buy
Analyst Count
3
6
Target Price
★ $8.33
$3.92
AVG Volume (30 Days)
901.9K
★ 8.6M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 119.51
93.94
EPS
★ 0.20
N/A
Revenue
★ $917,927,000.00
N/A
Revenue This Year
$5.33
N/A
Revenue Next Year
$1.09
N/A
P/E Ratio
$17.50
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.40
$0.54
52 Week High
$6.11
$1.89

Technical Indicators

Market Signals
Indicator
ALTO
AKBA
Relative Strength Index (RSI) 50.56 25.15
Support Level $3.46 N/A
Resistance Level $3.79 $1.54
Average True Range (ATR) 0.15 0.07
MACD 0.02 -0.01
Stochastic Oscillator 44.66 9.73

Price Performance

Historical Comparison
ALTO
AKBA

About ALTO Alto Ingredients Inc.

Alto Ingredients Inc is a producer and distributor of specialty alcohols, renewable fuels and essential ingredients in the United States. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, and Western production.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

Share on Social Networks: